量化多策略Quant multi-strategy · famous
Renaissance Technologies
文艺复兴科技
公开持仓Public holdings
13F-RS 研究可用度13F-RS research usability
47.1
覆盖coverage 75% · 置信confidence B
结论先行Answer first
前五大占7.4%，最值得继续核验的动作是增持META PLATFORMS INCTop five represent 7.4%; increase in META PLATFORMS INC is the clearest next diligence lead
最大可见非期权证券持仓为NVIDIA CORPORATION（2.0%）；季度快照换手代理为31.1%，前十大延续率为93.5%。该机构归入“量化多策略”，13F只能解释公开的美国可报告证券多头。
The largest visible non-option security is NVIDIA CORPORATION (2.0%). The quarterly snapshot turnover proxy is 31.1%, and top-ten persistence is 93.5%. The manager is classified as Quant/multi-strategy; 13F covers only visible reportable U.S. long securities.
按上季可见权重 × 股数降幅排序；完整非期权证券变化见下方。Ranked by prior visible weight × share decline; the full non-option security changes appear below.
下一步Next diligence
把增持META PLATFORMS INC作为研究线索，结合公司基本面、估值、催化剂及13D/G核验；不要直接跟单。
Treat the increase in META PLATFORMS INC as a research lead and verify fundamentals, valuation, catalysts and any 13D/G filings; do not copy mechanically.
CUSIP bridge · terminal event
公司行动换算与事件退出Corporate-action adjustments and event exits
下列旧证券没有被机械写成“清仓”。股票事件按权威比例恢复可比基线；现金/CVR并购没有 13F 继承证券，直接从卖出分类剔除。
These obsolete securities are not mechanically labeled as exits. Stock events use primary-source ratios to restore comparable baselines; cash/CVR mergers have no 13F successor and are excluded from sale classification.
| 生效日Effective | 上季证券Prior security | 可比证券 / 事件处置Comparable security / event treatment | 证据Evidence |
|---|---|---|---|
| 2026-04-27 | AMICUS THERAPEUTICSCUSIP 03152W109 · 1,872,893 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceBioMarin 完成收购；每股 14.50 美元现金，证券注销，不推断为管理人主动卖出BioMarin completed the acquisition for $14.50 cash per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-04-28 | ARCELLX INCCUSIP 03940C100 · 96,400 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceGilead 完成收购；每股 115 美元现金加一份 5 美元 CVR，证券注销，不推断为管理人主动卖出Gilead completed the acquisition for $115 cash plus one $5 CVR per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-05-05 | TERNS PHARMACEUTICALS INCCUSIP 880881107 · 169,034 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceMerck 完成要约收购及合并；每股 53 美元现金，证券注销，不推断为管理人主动卖出Merck completed the tender offer and merger for $53 cash per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-05-14 | TRI POINTE HOMES INCCUSIP 87265H109 · 200,236 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceSumitomo Forestry 完成收购；每股 47 美元现金，证券注销，不推断为管理人主动卖出Sumitomo Forestry completed the acquisition for $47 cash per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-05-14 | APELLIS PHARMACEUTICALS INCCUSIP 03753U106 · 935,958 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceBiogen 完成收购；每股 41 美元现金加一份最高 4 美元的 CVR，证券注销，不推断为管理人主动卖出Biogen completed the acquisition for $41 cash plus one CVR worth up to $4 per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-05-18 | SOLENO THERAPEUTICS INCCUSIP 834203309 · 447,300 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceNeurocrine 完成收购；每股 53 美元现金，证券注销，不推断为管理人主动卖出Neurocrine completed the acquisition for $53 cash per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-06-10 | MASIMO CORPCUSIP 574795100 · 239,500 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceDanaher 完成收购；每股 180 美元现金，证券注销，不推断为管理人主动卖出Danaher completed the acquisition for $180 cash per share; the security was cancelled, so no manager-initiated sale is inferred |
| 2026-06-24 | CENTESSA PHARMACEUTICALS PLCCUSIP 152309100 · 185,000 股shares | 现金/CVR 已结算；无 13F 继承证券。本项列入公司事件，不推断为主动卖出。Cash/CVR settled with no 13F successor security. This is recorded as a corporate event, not inferred as an active sale. | 核验来源Verification sourceLilly 完成收购；每股 38 美元现金加一份最高 9 美元的 CVR，ADS 注销，不推断为管理人主动卖出Lilly completed the acquisition for $38 cash plus one CVR worth up to $9 per share; the ADS was cancelled, so no manager-initiated sale is inferred |
| 2026-04-20 | ASCENDIS PHARMA A/SCUSIP 04351P101 · 117,332 股shares | ASCENDIS PHARMA A/SCUSIP K08588103权威比例基准 117,332 股；本季申报 119,699 股Primary-ratio baseline 117,332 shares; current filing 119,699 shares | 核验来源Verification sourceADS 按 1:1 强制转换为普通股并更换 CUSIPMandatory 1:1 ADS-to-ordinary-share exchange and CUSIP change |
| 2026-05-04 | THOMSON REUTERS CORPCUSIP 884903808 · 168,695 股shares | THOMSON REUTERS CORPCUSIP 884903881权威比例基准 166,090 股；本季申报 0 股Primary-ratio baseline 166,090 shares; current filing 0 shares | 核验来源Verification source资本返还后按 0.984560:1 合股并更换 CUSIP0.984560-for-1 share consolidation after a return of capital, with a CUSIP change |
| 2026-05-07 | CARNIVAL CORPCUSIP 143658300 · 2,598,300 股shares | CARNIVAL CORP LTDCUSIP G2004J103权威比例基准 2,598,300 股；本季申报 493,000 股Primary-ratio baseline 2,598,300 shares; current filing 493,000 shares | 核验来源Verification source公司结构简化及迁册，旧股按 1:1 对应新 CUSIPCorporate simplification and redomiciliation, with old shares mapped 1:1 to the new CUSIP |
| 2026-06-29 | HONEYWELL INTL INCCUSIP 438516106 · 375,300 股shares | HONEYWELL AEROSPACE INCCUSIP 43849R105权威比例基准 187,650 股；本季申报 0 股Primary-ratio baseline 187,650 shares; current filing 0 shares HONEYWELL INTL INCCUSIP 438516205权威比例基准 187,650 股；本季申报 0 股Primary-ratio baseline 187,650 shares; current filing 0 shares | 核验来源Verification source航天业务分拆，同时原公司 1:2 反向拆股并更换 CUSIPAerospace spin-off plus a 1-for-2 reverse split and CUSIP change for the remaining company |
| 2026-06-30 | MARQETA INCCUSIP 57142B104 · 11,580,288 股shares | MARQETA INCCUSIP 57142B203权威比例换算为 2,895,072 股；本季却申报 12,419,532 股，因口径冲突不计算变化Primary ratio implies 2,895,072 shares, while the current filing reports 12,419,532; no change is calculated because the conventions conflict季末报量口径冲突，本季只桥接身份、不分类买卖Quarter-end quantity convention conflict; identity bridged without trade classification | 核验来源Verification source1:4 反向拆股在季末收盘生效；部分13F用新CUSIP但仍报拆股前数量，本季只桥接身份、不推断交易A 1-for-4 reverse split took effect at the quarter-end close; some 13Fs use the new CUSIP with pre-split quantities, so this quarter bridges identity without inferring trading |
CIK · accession · accepted date
本季申报链Current filing chain
先展示 13F-NT 关系通知，再展示解析到的 13F-HR / HR-A。价值单位说明保留检测结果和归一化倍数。
Relationship notices appear before resolved 13F-HR / HR-A filings. Unit notes preserve the detection result and normalization multiplier.
| 法律申报人Legal filer | CIK | Form | Accession | 申报日Filed | 解析 / 单位说明Resolution / unit note |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | CIK 0001037389 | 13F-HR | 0001037389-26-000059 | 2026-08-13 | usd_consistent_with_implied_prices |
2026-03-31 → 2026-06-30
持仓与季度变化Holdings and quarterly change
前十大可见非期权证券Top visible non-option holdings 10
| 证券Security | Put / Call | 申报价值Filed value | 权重Weight | 股数 / 标的股数Shares / underlying shares | 股数变化Share change |
|---|---|---|---|---|---|
| NVIDIA CORPORATIONCOM · CUSIP 67066G104 | — | $1.42bn | 1.95% | 7,091,256 | 180.6% |
| META PLATFORMS INCCL A · CUSIP 30303M102 | — | $1.14bn | 1.57% | 2,023,153 | 698.5% |
| INTEL CORPCOM · CUSIP 458140100 | — | $1.02bn | 1.41% | 7,321,928 | -1.1% |
| UNITED THERAPEUTICS CORP DELCOM · CUSIP 91307C102 | — | $925.8m | 1.27% | 1,708,739 | -4.4% |
| PALANTIR TECHNOLOGIES INCCL A · CUSIP 69608A108 | — | $883.0m | 1.22% | 7,568,370 | 8.3% |
| ALPHABET INCCAP STK CL A · CUSIP 02079K305 | — | $828.2m | 1.14% | 2,317,438 | 327.2% |
| EXELIXIS INCCOM · CUSIP 30161Q104 | — | $730.6m | 1.01% | 13,427,993 | -2.2% |
| VERISIGN INCCOM · CUSIP 92343E102 | — | $616.3m | 0.85% | 2,449,771 | -13.1% |
| KINROSS GOLD CORPCOM · CUSIP 496902404 | — | $584.5m | 0.81% | 24,747,213 | -3.1% |
| CROWDSTRIKE HLDGS INCCL A · CUSIP 22788C105 | — | $571.6m | 0.79% | 748,960 | — |
新建仓位New positions 10
| 证券Security | Put / Call | 申报价值Filed value | 权重Weight | 股数 / 标的股数Shares / underlying shares | 股数变化Share change |
|---|---|---|---|---|---|
| CROWDSTRIKE HLDGS INCCL A · CUSIP 22788C105 | — | $571.6m | 0.79% | 748,960 | — |
| AMAZON COM INCCOM · CUSIP 023135106 | — | $546.0m | 0.75% | 2,290,710 | — |
| MEDTRONIC PLCSHS · CUSIP G5960L103 | — | $247.8m | 0.34% | 3,167,741 | — |
| CONOCOPHILLIPSCOM · CUSIP 20825C104 | — | $210.3m | 0.29% | 2,022,465 | — |
| SHELL PLCSPON ADS · CUSIP 780259305 | — | $209.0m | 0.29% | 2,695,452 | — |
| INTUITCOM · CUSIP 461202103 | — | $199.7m | 0.28% | 765,048 | — |
| SCHWAB CHARLES CORPCOM · CUSIP 808513105 | — | $176.3m | 0.24% | 1,911,141 | — |
| STATE STR SPDR S&P 500 ETF TTR UNIT · CUSIP 78462F103 | — | $163.6m | 0.23% | 219,040 | — |
| INTERCONTINENTAL EXCHANGE INCOM · CUSIP 45866F104 | — | $156.3m | 0.21% | 1,269,289 | — |
| INVESCO QQQ TRUNIT SER 1 · CUSIP 46090E103 | — | $150.7m | 0.21% | 204,600 | — |
增持仓位Added positions 10
| 证券Security | Put / Call | 申报价值Filed value | 权重Weight | 股数 / 标的股数Shares / underlying shares | 股数变化Share change |
|---|---|---|---|---|---|
| META PLATFORMS INCCL A · CUSIP 30303M102 | — | $1.14bn | 1.57% | 2,023,153 | 698.5% |
| NVIDIA CORPORATIONCOM · CUSIP 67066G104 | — | $1.42bn | 1.95% | 7,091,256 | 180.6% |
| ALPHABET INCCAP STK CL A · CUSIP 02079K305 | — | $828.2m | 1.14% | 2,317,438 | 327.2% |
| ALPHABET INCCAP STK CL C · CUSIP 02079K107 | — | $556.8m | 0.77% | 1,575,815 | 684.0% |
| NETFLIX INC.COM · CUSIP 64110L106 | — | $484.7m | 0.67% | 6,787,884 | 275,718.1% |
| ADVANCED MICRO DEVICES INCCOM · CUSIP 007903107 | — | $463.8m | 0.64% | 829,697 | 282.4% |
| TESLA INCCOM · CUSIP 88160R101 | — | $467.3m | 0.64% | 1,110,960 | 425.8% |
| SEAGATE TECHNOLOGY HLDNGS PLORD SHS · CUSIP G7997R103 | — | $441.3m | 0.61% | 457,353 | 47.3% |
| PALANTIR TECHNOLOGIES INCCL A · CUSIP 69608A108 | — | $883.0m | 1.22% | 7,568,370 | 8.3% |
| TEXAS INSTRS INCCOM · CUSIP 882508104 | — | $417.9m | 0.58% | 1,402,100 | 64.7% |
减持仓位Reduced positions 10
用公司行动调整后的股数判断，按上季可见权重 × 股数降幅排序；报告权重变化不是交易量。Classified from corporate-action-adjusted shares and ranked by prior visible weight × share decline; reported weight change is not trading volume.
| 证券Security | Put / Call | 申报价值Filed value | 权重Weight | 股数 / 标的股数Shares / underlying shares | 股数变化Share change |
|---|---|---|---|---|---|
| MICRON TECHNOLOGY INCCOM · CUSIP 595112103 | — | $244.2m | 0.34% | 211,580 | -90.2% |
| SANDISK CORPCOM · CUSIP 80004C200 | — | $11.3m | 0.02% | 4,980 | -99.4% |
| APPLE INCCOM · CUSIP 037833100 | — | $459.1m | 0.63% | 1,586,526 | -48.4% |
| LINDE PLCSHS · CUSIP G54950103 | — | $2.6m | 0.00% | 5,100 | -99.2% |
| VERTIV HOLDINGS COCOM CL A · CUSIP 92537N108 | — | $10.3m | 0.01% | 30,758 | -96.8% |
| UNITEDHEALTH GROUP INCCOM · CUSIP 91324P102 | — | $152.5m | 0.21% | 367,014 | -68.3% |
| ROBINHOOD MKTS INCCOM CL A · CUSIP 770700102 | — | $220.2m | 0.30% | 2,196,340 | -57.0% |
| NU HLDGS LTDORD SHS CL A · CUSIP G6683N103 | — | $37.8m | 0.05% | 2,828,056 | -82.6% |
| VISA INCCOM CL A · CUSIP 92826C839 | — | $42.3m | 0.06% | 123,291 | -81.8% |
| WESTERN DIGITAL CORPCOM · CUSIP 958102105 | — | $343.3m | 0.47% | 537,473 | -53.1% |
退出候选Apparent exits 10
仅表示排除已知公司事件后，本期未见同一可比证券；到期、退市及未知事件仍须核验。Only means the comparable security is absent after known event checks; maturities, delistings and unknown events still require review.
| 证券Security | Put / Call | 申报价值Filed value | 权重Weight | 股数 / 标的股数Shares / underlying shares | 股数变化Share change |
|---|---|---|---|---|---|
| APPLOVIN CORPCOM CL A · CUSIP 03831W108 | — | $173.7m | 0.27% | 436,540 | -100.0% |
| VANECK ETF TRUSTSEMICONDUCTR ETF · CUSIP 92189F676 | — | $141.7m | 0.22% | 369,487 | -100.0% |
| UBER TECHNOLOGIES INCCOM · CUSIP 90353T100 | — | $129.2m | 0.20% | 1,796,200 | -100.0% |
| SERVICENOW INCCOM · CUSIP 81762P102 | — | $126.1m | 0.20% | 1,206,018 | -100.0% |
| UNITED PARCEL SVCS INCCL B · CUSIP 911312106 | — | $121.5m | 0.19% | 1,234,600 | -100.0% |
| PDD HOLDINGS INCSPONSORED ADS · CUSIP 722304102 | — | $113.7m | 0.18% | 1,112,700 | -100.0% |
| MORGAN STANLEYCOM NEW · CUSIP 617446448 | — | $110.9m | 0.17% | 674,111 | -100.0% |
| AMERICAN AIRLINES GROUP INCCOM · CUSIP 02376R102 | — | $104.0m | 0.16% | 9,687,232 | -100.0% |
| DEERE & COCOM · CUSIP 244199105 | — | $102.5m | 0.16% | 181,942 | -100.0% |
| MASTERCARD INCORPORATEDCL A · CUSIP 57636Q104 | — | $97.3m | 0.15% | 194,651 | -100.0% |
期权切片Options slice 0
Put/Call 股数是标的股数；13F 没有执行价、到期日、权利金或净方向。Put/call shares are underlying shares; 13F omits strike, expiry, premium and net direction.
| 证券Security | Put / Call | 申报价值Filed value | 权重Weight | 股数 / 标的股数Shares / underlying shares | 股数变化Share change |
|---|---|---|---|---|---|
| 无可展示记录No records to display | |||||
13F-RS-v1.0
评分拆解Score breakdown
| 维度Dimension | 得分Score | 相对满分Relative to max | 比例Ratio |
|---|---|---|---|
| 申报完整性Filing integrity | 15.0 / 15 | 100% | |
| 实体映射Entity mapping | 10.0 / 10 | 100% | |
| 策略适配度Strategy fit | 5.2 / 15 | 35% | |
| 集中度信息密度Concentration signal | 0.2 / 10 | 2% | |
| 高确信度可识别性Conviction identifiability | 0.5 / 15 | 3% | |
| 延续性 / 换手Persistence / turnover | 7.9 / 10 | 79% | |
| 申报时滞Filing lag | 0.3 / 10 | 3% | |
| 不可见风险Opacity risk | 8.0 / 10 | 80% | |
| 独立共识Independent consensus | 0.0 / 5 | 0% |
策略分类：量化多策略。分数衡量公开13F的研究可用度，不评价未来收益。Strategy classification: Quant multi-strategy. The score measures public-13F research usability, not future returns.
H（高确信度可识别性）当前以单仓≥2%为有限代理，尚未接入风格基准主动权重，因此该分项覆盖度只有50%。H (conviction identifiability) currently uses positions ≥2% as a limited proxy; style-benchmark active weights are not yet available, so this component has only 50% coverage.